Crestor Study Sidesteps Suspicious Statin Side Effects

Filed under: Misc — Tags: , , , , , — @ November 11, 2008


Popular statin Crestor now recommended for low cholesterol…HUH?

Whenever you read a study that calls for an increase in the use of a prescription drug for an even larger group of people, look out. You can almost bet the funding for such a study comes from the pharmaceutical company that stands to profit the most from such a proclamation (I’ve previously blogged about this happening in the artificial sweetener industry). And that is precisely what happened on Monday when drug manufacturer AstraZeneca released the results of a study about their cash cow pill for high-cholesterol called Crestor at the American Heart Association’s Scientific Sessions in New Orleans, Louisiana.

There’s a whole lot more to this story than what you read about online or heard on your evening news. To get the full scoop on this study and what it means, click here.

About

CarbWire is an online magazine of everything low-carb. Whether you're already on a diet, or are just doing research, we provide the most up-to-date info on the web.

Search

By topic

CarbWire RSS Feed Add to MyYahoo

Content Copyright © 2004-2017 CarbWire.com